Product Information
SumiLarv™ 0.5G is a granule formulation containing 0.5% w/w pyriproxyfen. SumiLarv 0.5G prevents mosquito pupae from developing into flying adult mosquitoes which can later bite humans. SumiLarv 0.5G has been developed by Sumitomo Chemical Co., Ltd.
Key Features
- Effective at very low dose rates
- Active against Aedes and Anopheles mosquito species
- Long duration of activity under field conditions
- Unique mode of action
- Useful in resistance prevention or resistance management programmes
- Low mammalian toxicity
- Effects on fertility, mating, and sperm development of surviving emerged adults